VENUS REMEDIES
Back to Income Statement
|
VENUS REMEDIES Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹41 Cr | ₹62 Cr | ₹-10.00 Cr | ₹-29 Cr | ₹-31 Cr |
What is the latest Consolidated Net Profit of VENUS REMEDIES ?
Year | Consolidated Net Profit |
---|---|
Mar2023 | ₹41 Cr |
Mar2022 | ₹62 Cr |
Mar2021 | ₹-10.00 Cr |
Mar2020 | ₹-29 Cr |
Mar2019 | ₹-31 Cr |
How is Consolidated Net Profit of VENUS REMEDIES Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2023 | ₹41 Cr | -34.07 | |
Mar2022 | ₹62 Cr | Positive | |
Mar2021 | ₹-10.00 Cr | Negative | |
Mar2020 | ₹-29 Cr | Negative | |
Mar2019 | ₹-31 Cr | - |
Compare Consolidated Net Profit of peers of VENUS REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VENUS REMEDIES | ₹428.3 Cr | -2.7% | -5.6% | 53.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | 0.3% | -7.5% | 53.9% | Stock Analytics | |
CIPLA | ₹115,034.0 Cr | 1.1% | -4.8% | 56.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.6% | 1.6% | 27.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,873.0 Cr | -1.9% | 10.7% | 21.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 5.2% | -0.2% | 90.1% | Stock Analytics |
VENUS REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VENUS REMEDIES | -2.7% |
-5.6% |
53.9% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses